124 related articles for article (PubMed ID: 5284087)
1. Hypertrophic gastropathy with hypersecretion and gastric protein loss.
Roberts HJ
Aust N Z J Med; 1971 Feb; 1(1):69-71. PubMed ID: 5284087
[No Abstract] [Full Text] [Related]
2. Hypertrophic, hypersecretory protein-losing gastropathy.
Overholt BF; Jeffries GH
Gastroenterology; 1970 Jan; 58(1):80-7. PubMed ID: 5410458
[No Abstract] [Full Text] [Related]
3. The treatment of carotid sinus syncope with propantheline.
Palmer RA
Can Med Assoc J; 1971 May; 104(10):923-5. PubMed ID: 5574060
[No Abstract] [Full Text] [Related]
4. Amylopectin sulfate, propantheline and recurrent duodenal ulcer.
Littman A
Gastroenterology; 1970 Jun; 58(6):913-4. PubMed ID: 4912660
[No Abstract] [Full Text] [Related]
5. The treatment of enuresis: a controlled clinical trial of propantheline, propantheline-and-phenobarbitone and a placebo.
Wallace IR; Forsythe WI
Br J Clin Pract; 1969 May; 23(5):207-10. PubMed ID: 4889506
[No Abstract] [Full Text] [Related]
6. Giant thickening of the gastric mucosa with acid hypersecretion and protein-losing gastropathy.
Brooks AM; Isenberg J; Goldstein H
Gastroenterology; 1970 Jan; 58(1):73-9. PubMed ID: 5410456
[No Abstract] [Full Text] [Related]
7. A controlled study on the use of propantheline and amylopectin sulfate (SN-263) for recurrences in duodenal ulcer.
Sun DC; Ryan ML
Gastroenterology; 1970 Jun; 58(6):756-61. PubMed ID: 4912656
[No Abstract] [Full Text] [Related]
8. Ocular effects of Pro-Banthine.
Gokhale AM; Gokhale SA
Br J Ophthalmol; 1970 Oct; 54(10):683-6. PubMed ID: 5472198
[No Abstract] [Full Text] [Related]
9. A comparison of oxyphencyclimine hydrochloride and propantheline bromide in patients with duodenal ulcer.
Alea JA; Aquilina JT
Am J Dig Dis; 1967 Nov; 12(11):1122-30. PubMed ID: 4383347
[No Abstract] [Full Text] [Related]
10. A biochemical-cellular-morphological explanation for antiulcerogenic effects of parasympatholytics and of surgical vagotomy in Shay rats.
Mózsik G; Kiss B; Krausz M; Jávor T
Scand J Gastroenterol; 1969; 4(8):641-51. PubMed ID: 4392787
[No Abstract] [Full Text] [Related]
11. [Protein-losing hypertrophic hypersecretory gastropathy].
Kornél S; Arpád G; Tamás B
Orv Hetil; 1976; 117(18):1098-100. PubMed ID: 1272565
[No Abstract] [Full Text] [Related]
12. Further observations upon gastric function in rats after prolonged administration of an anticholinergic drug, propantheline bromide.
Kaye MD
Am J Dig Dis; 1969 Nov; 14(11):770-81. PubMed ID: 5358879
[No Abstract] [Full Text] [Related]
13. [Control of changes in emotional tension by the heart].
Santana ET; Sabbag M; Seixas A; Tashima F; Marchiotto O; Yamagichi N; Santana MA
Hospital (Rio J); 1968 Nov; 74(5):1695-700. PubMed ID: 5305346
[No Abstract] [Full Text] [Related]
14. [Gastric secretion in hypertrophic gastropathy with plical gigantism (Ménétrier's disease)].
Faggioli F; Masiello O; De Florio L; Frizziero L; Patroncini F
G Clin Med; 1969 Jun; 50(6):488-503. PubMed ID: 5386607
[No Abstract] [Full Text] [Related]
15. [Controlled clinical study of the oral use of Ketoscilium in dyskinetic-spastic disorders of the digestive tract].
Maduli S; Frigerio G
Minerva Gastroenterol; 1970; 16(2):94-8. PubMed ID: 5477402
[No Abstract] [Full Text] [Related]
16. Hypertrophic protein-losing gastropathy and vitiligo. Report of a second case.
Berkowitz DM; Passaro E; Isenberg JI
Am J Dig Dis; 1977 Jun; 22(6):554-7. PubMed ID: 868835
[TBL] [Abstract][Full Text] [Related]
17. [Clinical examination of Dolo-Tensilan in gynecology].
Vogler H
Med Welt; 1970 Dec; 51():2202-7. PubMed ID: 5509499
[No Abstract] [Full Text] [Related]
18. [Therapeutic experiences with a central sedative and peripheral analgesic-spasmolytic medication combination in gastrointestinal diseases].
Lampe W
Med Welt; 1968 Jun; 23():1427-30. PubMed ID: 5718202
[No Abstract] [Full Text] [Related]
19. [Treatment of hyperacid stomach patients using the combination preparation Praxiten SP].
Ohlenschläger G; Schmidt KH
Ther Ggw; 1974 Feb; 113(2):234-5 passim. PubMed ID: 4826175
[No Abstract] [Full Text] [Related]
20. [On the use of anticholinergic drugs in arrhythmia and conduction disorders].
Streian C; Luca C; Cocheci M
Med Interna (Bucur); 1970 Dec; 22(12):1465-74. PubMed ID: 5502467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
